allogeneic cytokine-induced memory-like NK cells WU-NK-101
Term · Oncology and biomedicine · MLC-T-ONC-009874
A population of off-the-shelf (OTS) donor-derived cytokine-induced, memory-like, cytotoxic natural killer (NK) cells (CIML NKs) containing NK cell-activating surface receptors, with potential immunomodulating and antineoplastic activities. The allogeneic NK cells are pre-activated ex vivo using the human-derived cytokines interleukin (IL)-12, IL-15, and IL-18, which induces the differentiation of the NK cells into CIML NK cells, which contain more NK cell-activating surface receptors. The pretreated NK cells exhibit enhanced activation and increased production of the cytokine interferon-gamma (IFN-g), and may exert enhanced cytotoxicity against tumor cells, including enhanced antibody-dependent cellular cytotoxicity (ADCC). Upon administration, the CIML NKs WU-NK-101 may induce an anti-tumor immune response and kill tumor cells.
| Identifier | MLC-T-ONC-009874 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic CIML NKs WU-NK-101; donor-derived CIML NKs WU-NK-101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009874",
"term": "allogeneic cytokine-induced memory-like NK cells WU-NK-101",
"field": "Oncology and biomedicine",
"definition": "A population of off-the-shelf (OTS) donor-derived cytokine-induced, memory-like, cytotoxic natural killer (NK) cells (CIML NKs) containing NK cell-activating surface receptors, with potential immunomodulating and antineoplastic activities. The allogeneic NK cells are pre-activated ex vivo using the human-derived cytokines interleukin (IL)-12, IL-15, and IL-18, which induces the differentiation of the NK cells into CIML NK cells, which contain more NK cell-activating surface receptors. The pretreated NK cells exhibit enhanced activation and increased production of the cytokine interferon-gamma (IFN-g), and may exert enhanced cytotoxicity against tumor cells, including enhanced antibody-dependent cellular cytotoxicity (ADCC). Upon administration, the CIML NKs WU-NK-101 may induce an anti-tumor immune response and kill tumor cells.",
"synonyms": [
"allogeneic CIML NKs WU-NK-101",
"donor-derived CIML NKs WU-NK-101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-cytokine-induced-memory-like-nk-cells-wu-nk-101/"
}
Record 760 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.